Transaction · 0001628280-26-058648

Curran Terrie

Curran Terrie, DIR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 1072.000000 shares for an estimated $27912.31. Reported holdings after the transaction were 23526.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
ARQTArcutis Biotherapeutics, Inc.
Trade date
Aug 20, 2026
Filing date
Aug 24, 2026
View on SEC Insider profile
Estimated value-$27.9kShares × reported price
Shares traded1.07k$26.04 per share
Holdings after23.5kDirect
% of reported position traded4.36%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 24,598 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ARQT price since this filing

Daily closing prices, with the filing date and available return windows
ARQT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +14.0%1w ago +4.2%1d ago +6.8%
Returns since7d -3.3%30d +6.5%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-058648
Common Stock
Transaction date
Aug 20, 2026
Filed Aug 24, 2026, 08:19 PM · 4d delay
Shares
1,072 sh
$26.04 per share
Estimated value
-$27.9k
Computed from shares × price
Holdings after
23,526 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.

  2. F2

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.2228, inclusive. The Reporting Person hereby underta…

  3. F3

    The option is fully vested.

Original filing · 0001628280-26-058648
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ARQT